[Triptans in migraine: a comparative review of pharmacology, pharmacokinetics].
Kato
Kazumasa
K
Department of Hospital Pharmacy, Kyorin University Hospital of Medicine, 6-20-2 Shinkawa, Mitaka-shi, Tokyo 181-8611, Japan.
D000818:Animals; D001682:Biological Availability; D002319:Cardiovascular System / Q000187:drug effects; D004305:Dose-Response Relationship, Drug; D006801:Humans; D007211:Indoles / Q000493:pharmacokinetics / Q000494:pharmacology / Q000627:therapeutic use; D008881:Migraine Disorders / Q000188:drug therapy* / Q000378:metabolism; D023303:Oxazolidinones / Q000493:pharmacokinetics / Q000494:pharmacology / Q000627:therapeutic use; D011759:Pyrrolidines / Q000493:pharmacokinetics / Q000494:pharmacology / Q000627:therapeutic use; D044346:Receptor, Serotonin, 5-HT1D / Q000627:therapeutic use; D017366:Serotonin Receptor Agonists / Q000493:pharmacokinetics / Q000494:pharmacology* / Q000627:therapeutic use; D018170:Sumatriptan / Q000493:pharmacokinetics* / Q000494:pharmacology* / Q000627:therapeutic use; D014363:Tryptamines
D007211:Indoles; D023303:Oxazolidinones; D011759:Pyrrolidines; D044346:Receptor, Serotonin, 5-HT1D; D017366:Serotonin Receptor Agonists; D014363:Tryptamines; C115647:eletriptan; C089750:zolmitriptan; D018170:Sumatriptan